EKF Diagnostics HoldingsLSE:EKF 52 OCF Yield % is 8.58 as of Jul. 04, 2026, which is 52% above its 10-year median of 5.63. GuruFocus rates LSE:EKF with a GF Score™ of 52/100 and a GF Value™ of £0.28 (Fairly Valued). The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, EKF Diagnostics Holdings ranks better than 80.91% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for EKF Diagnostics Holdings's OCF Yield % or its related term are showing as below:
LSE:EKF'
s OCF Yield % Range Over the Past 10 Years
Min: -6.87 Med: 5.63 Max: 15.43
Current: 8.58
During the past 13 years, the highest OCF Yield % of EKF Diagnostics Holdings was 15.43%. The lowest was -6.87%. And the median was 5.63%.
LSE:EKF's OCF Yield % is ranked better than 80.91% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.68
vs LSE:EKF: 8.58
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
EKF Diagnostics Holdings OCF Yield % Related Terms
EKF Diagnostics Holdings OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, EKF Diagnostics Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's OCF Yield % distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKF Diagnostics Holdings (LSE:EKF) has a OCF Yield % of 8.58 as of Jul. 04, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on EKF Diagnostics Holdings and its competitors. This is 52% above median its historical median of 5.63. According to the industry distribution chart, EKF Diagnostics Holdings ranks #163 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 19.1%.
Is EKF Diagnostics Holdings' OCF Yield % too high?
EKF Diagnostics Holdings' current OCF Yield % of 8.58 is 52% above median its 10-year median of 5.63. The Medical Devices & Instruments industry median OCF Yield % is 1.68. EKF Diagnostics Holdings' value of 8.58 is 410.7% above this industry median. Based on the distribution chart, EKF Diagnostics Holdings ranks #163 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, EKF Diagnostics Holdings has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EKF Diagnostics Holdings ranks #163 out of 854 companies for OCF Yield %. This places EKF Diagnostics Holdings in the top 19% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.68. EKF Diagnostics Holdings' value of 8.58 is 410.7% above this benchmark. While the company's 10-year median is 5.63 vs. the industry median of 1.68, EKF Diagnostics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.68, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EKF Diagnostics Holdings's current OCF Yield % of 8.58 is 410.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on EKF Diagnostics Holdings and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EKF Diagnostics Holdings's current OCF Yield % is 8.58, which is 52% above median its own 10-year median of 5.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.26 — trading 6.1% below its estimated fair value. The current OCF Yield % is 8.58, which is 52% above median its 10-year median of 5.63 and 410.7% above the Medical Devices & Instruments industry median of 1.68. EKF Diagnostics Holdings' overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current OCF Yield % is 8.58 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of £0.26 is trading 6.1% below its estimated GF Value™ of £0.28.
GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.
Key valuation signals for LSE:EKF:
OCF Yield %: 8.58 (52% above median its 10-year median of 5.63)
GF Value™: £0.28 vs. price of £0.26 (6.1% below fair value)
Industry Position: 410.7% above the Medical Devices & Instruments median (#163 of 854)
No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
52GF Score
Get the complete analysis for LSE:EKF
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:EKF has been successfully added to your 
